TXMD

$1.78-1.66%visit website

TherapeuticsMD, Inc.

Market Cap

$21M

Live price × SEC shares (Aug 9, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.70

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

6.3

TTM to Jun 2026 · revenue

P/B

0.8

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	784	893	724	869	3,270
Total operating expenses	1,646	2,445	1,447	1,685	7,223
Operating income	(862)	(1,552)	(723)	(816)	(3,953)
Pretax income	50	(580)	103	164	(263)
Income tax	0.00
Net income	152	(619)	95	155	(217)
EPS (basic) ($)	0.01		0.01	0.01	(0.02)
EPS (diluted) ($)	0.01		0.01	0.01	(0.02)
Weighted avg. shares (basic)	11,574		—	11,574
Weighted avg. shares (diluted)	11,574		—	11,643

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 11, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 60 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

6 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Aug 11, 2026 accepted 4:00 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 12, 2026 accepted 4:10 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 30, 2026 accepted 5:56 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 21, 2026 accepted 5:43 PM ET	4.01Auditor change	Document SEC ↗
Dec 16, 2025 accepted 4:01 PM ET	5.07Shareholder vote	Document SEC ↗
Nov 13, 2025 accepted 8:54 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 12, 2025 accepted 4:16 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 13, 2025 accepted 4:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Apr 9, 2025 accepted 6:30 AM ET	8.01Other events	Document SEC ↗
Mar 27, 2025 accepted 4:30 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

W/W -42.6pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors

MarketWatch · 2026-11-03

TherapeuticsMD Inc (NASDAQ: TXMD) Share Price, TXMD Stock News, TXMD Share Price & Updates

kalkine.ca · 2026-11-02

TherapeuticsMD Inc. Advanced Charts | TXMD

Barron's · 2026-11-01

TXMD | TherapeuticsMD Inc. Stock Overview (U.S.: Nasdaq)

Barron's · 2026-11-01

TherapeuticsMD(TXMD) Stock Options Chain | Quotes & News

Moomoo · 2026-11-01

TherapeuticsMD Inc. stock outperforms competitors on strong trading day

MarketWatch · 2026-10-29

TXMD Q3 2023 Earnings: Wider-Than-Expected Loss Per Share Draws Attention Despite Modest Stock Uptick - Forward Guidance Trends

https://www.siam.in/ · 2026-10-28

TherapeuticsMD Announces Second Quarter 2026 Financial Results

Yahoo Finance · 2026-08-11

symbol__ Stock Quote Price and Forecast

CNN · 2023-08-30

Informational purposes only, not investment advice.

Corporate Events (8-K)

6 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Aug 11, 2026 accepted 4:00 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 12, 2026 accepted 4:10 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Mar 30, 2026 accepted 5:56 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Jan 21, 2026 accepted 5:43 PM ET	4.01Auditor change	Document SEC ↗
Dec 16, 2025 accepted 4:01 PM ET	5.07Shareholder vote	Document SEC ↗
Nov 13, 2025 accepted 8:54 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Aug 12, 2025 accepted 4:16 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
May 13, 2025 accepted 4:15 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗
Apr 9, 2025 accepted 6:30 AM ET	8.01Other events	Document SEC ↗
Mar 27, 2025 accepted 4:30 PM ET	2.02Earnings release7.01Reg FD disclosure	Document SEC ↗

TXMD

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

TherapeuticsMD, Inc. (TXMD)

Factor Profile

Corporate Events (8-K)